相似文献
1
High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma.
Br J Cancer. 1999 Feb;79(5-6):821-4. doi: 10.1038/sj.bjc.6690131.
2
Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative.
Arch Ophthalmol. 1996 Feb;114(2):186-92. doi: 10.1001/archopht.1996.01100130180013.
3
Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness.
Ophthalmology. 1996 Dec;103(12):2029-36. doi: 10.1016/s0161-6420(96)30391-6.
4
Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.
Photochem Photobiol. 1998 Sep;68(3):377-81.
5
Photodynamic therapy using Verteporfin (benzoporphyrin derivative monoacid ring A, BPD-MA) and 630 nm laser light in canine esophagus.
Lasers Surg Med. 2002;30(1):26-30. doi: 10.1002/lsm.10014.
6
Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis.
Photochem Photobiol. 1998 Jan;67(1):133-9.
7
Modified polyvinyl alcohol-benzoporphyrin derivative conjugates as phototoxic agents.
Photochem Photobiol. 1993 Apr;57(4):641-7. doi: 10.1111/j.1751-1097.1993.tb02930.x.
8
Tissue uptake study and photodynamic therapy of melanoma-bearing mice with a nontoxic, effective chlorin.
ChemMedChem. 2011 Sep 5;6(9):1715-26. doi: 10.1002/cmdc.201100186. Epub 2011 Jul 5.
9
Clinical pharmacokinetics of anti-angiogenic photodynamic therapy with benzoporphyrin derivative monoacid ring-A in dogs having naturally occurring neoplasms.
J Vet Med A Physiol Pathol Clin Med. 2006 Mar;53(2):108-12. doi: 10.1111/j.1439-0442.2006.00802.x.
10
Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD).
Br J Cancer. 1999 Apr;79(11-12):1702-8. doi: 10.1038/sj.bjc.6690271.
引用本文的文献
1
The role of yes activated protein (YAP) in melanoma metastasis.
iScience. 2024 Apr 30;27(6):109864. doi: 10.1016/j.isci.2024.109864. eCollection 2024 Jun 21.
2
The fusion of light and immunity: Advancements in photoimmunotherapy for melanoma.
Photochem Photobiol. 2024 Jul-Aug;100(4):910-922. doi: 10.1111/php.13951. Epub 2024 Apr 16.
3
Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery.
Adv Sci (Weinh). 2024 May;11(17):e2302872. doi: 10.1002/advs.202302872. Epub 2024 Mar 6.
4
Paclitaxel-Loaded Lipid-Coated Magnetic Nanoparticles for Dual Chemo-Magnetic Hyperthermia Therapy of Melanoma.
Pharmaceutics. 2023 Mar 2;15(3):818. doi: 10.3390/pharmaceutics15030818.
5
In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001481.
6
Dual-Agent Photodynamic Therapy with Optical Clearing Eradicates Pigmented Melanoma in Preclinical Tumor Models.
Cancers (Basel). 2020 Jul 18;12(7):1956. doi: 10.3390/cancers12071956.
7
The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma.
Nanomedicine (Lond). 2019 Aug;14(15):2027-2043. doi: 10.2217/nnm-2019-0094. Epub 2019 Jun 5.
8
The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.
J Cancer. 2019 Jan 1;10(1):1-10. doi: 10.7150/jca.27472. eCollection 2019.
9
Association studies to transporting proteins of fac-Re(CO)(pterin)(HO) complex.
J Biol Inorg Chem. 2017 Jan;22(1):99-108. doi: 10.1007/s00775-016-1410-7. Epub 2016 Nov 4.
10
Photodynamic therapy of melanoma using new, synthetic porphyrins and phthalocyanines as photosensitisers - a comparative study.
Clujul Med. 2015;88(2):175-80. doi: 10.15386/cjmed-419. Epub 2015 Apr 15.
本文引用的文献
1
Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.
Photochem Photobiol. 1998 Sep;68(3):377-81.
2
New applications in photodynamic therapy. Introduction.
Photochem Photobiol. 1996 Nov;64(5):737-9. doi: 10.1111/j.1751-1097.1996.tb01828.x.
3
Effect of photosensitizer delivery system and irradiation parameters on the efficiency of photodynamic therapy of B16 pigmented melanoma in mice.
Photochem Photobiol. 1996 Feb;63(2):224-8. doi: 10.1111/j.1751-1097.1996.tb03018.x.
4
Photodynamic therapy of B16 pigmented melanoma with liposome-delivered Si(IV)-naphthalocyanine.
Photochem Photobiol. 1994 Mar;59(3):362-5. doi: 10.1111/j.1751-1097.1994.tb05048.x.
5
Histological comparison of the B16 melanoma and its F1 variant.
Cancer Lett. 1984 Aug;24(1):57-63. doi: 10.1016/0304-3835(84)90080-6.
6
Photosensitizers: therapy and detection of malignant tumors.
Photochem Photobiol. 1987 Jun;45(6):879-89. doi: 10.1111/j.1751-1097.1987.tb07898.x.
7
Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies.
Br J Cancer. 1990 Dec;62(6):966-70. doi: 10.1038/bjc.1990.418.
8
Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice.
J Photochem Photobiol B. 1990 Apr 15;5(2):231-44. doi: 10.1016/1011-1344(90)80008-l.
9
The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative.
Photochem Photobiol. 1991 Nov;54(5):709-15. doi: 10.1111/j.1751-1097.1991.tb02079.x.
Zotero 插件